戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 chedule to usual care, CFT only, or CFT plus biofeedback.
2 loperamide plus anorectal manometry-assisted biofeedback.
3 n with biomedical implants that can adapt to biofeedback.
4 63%]) and absence (46 [37%]) of vibrotactile biofeedback.
5 operamide and biofeedback versus placebo and biofeedback (-1.9 points, -4.1 to 0.3, p=0.092) or versu
6 n that can be taught using electromyographic biofeedback, achieving the therapeutic goal of reducing
7 iofeedback plus surgery vs. surgery alone or biofeedback alone) are also needed.
8 nal and physiological well-being through HRV biofeedback and coherence practices.
9 plus in-office, dual-channel electromyograph biofeedback and daily home pelvic floor electrical stimu
10                              The addition of biofeedback and pelvic floor electrical stimulation did
11                      The interaction between biofeedback and relaxation, highlighting activity unique
12     In this randomized clinical trial, video biofeedback and RRT were not different in the treatment
13 : biofeedback relaxation, relaxation without biofeedback and two corresponding control conditions in
14  target-specific botulinum toxin injections, biofeedback and, in severe refractory adults, psychosurg
15 164 (33%) to CFT only, 163 (33%) to CFT plus biofeedback, and 165 (34%) to usual care.
16 ombining loperamide, anal manometry-assisted biofeedback, and a standard educational pamphlet, but th
17 perant conditioning of neural activity using biofeedback, and from BCI/BMI studies in which neural ac
18 nce were seen with repetitive task training, biofeedback, and training with a moving platform.
19 l-based computer-assisted sphincter pressure biofeedback; and (4) hospital biofeedback plus the use o
20 ducational pamphlet, and that loperamide and biofeedback are equivalent to oral placebo and biofeedba
21 , meditation, controlled slow breathing, and biofeedback, are also appropriate to consider and merit
22 ewers, and outcome evaluators were masked to biofeedback assignment.
23 ly assigned to receive 8 weeks (4 visits) of biofeedback-assisted behavioral training (n = 73), 8 wee
24 s were randomized to 4 sessions (8 weeks) of biofeedback-assisted behavioral treatment, drug treatmen
25 nts were assigned randomly to receive either biofeedback-assisted cognitive-behavioral treatment (BF/
26 fers an important alternative to traditional biofeedback-based approaches and may be useful in the de
27  parameters and physiotherapy with anorectal biofeedback (BF) treatment.
28    We implemented this method in a real-time biofeedback brain-machine interface, and found that monk
29 t increases in activity were associated with biofeedback compared with random feedback.
30 cle relaxants or NSAIDS), topical capsaicin, biofeedback, corticosteroid injection (with or without N
31 nal study suggest that use of a vibrotactile biofeedback device to quantify and mitigate ergonomic ri
32 occupational tasks where it could serve as a biofeedback device to warn against excessive and clinica
33 back plus the use of a home electromyelogram biofeedback device.
34                         Continuous kinematic biofeedback during exercise interventions can lead to im
35 (fNIRS) NF to a semi-active electromyography biofeedback (EMG-BF) control condition regarding changes
36 dmill training, auditory stimulation, visual biofeedback, etc.) train gait toward symmetry.
37  studied in the Heart Rate Variability (HRV) biofeedback field, comprising 1.8 million user sessions
38                              Microperimetric biofeedback fixation training (BFT) can stabilize visual
39                                    Anorectal biofeedback for children has been proposed, but its effi
40 evaluating treatment efficacy, and providing biofeedback for rehabilitation exercises.
41 rtions of the gait cycle, providing valuable biofeedback for targeted gait retraining.
42                              Patients in the biofeedback group (n = 19) learned to correct abdominoph
43 tients in both groups (14 of 22 [64%] in the biofeedback group and 12 of 19 [63%] in the RRT group) s
44  by a mean (SD) of 3.54 (4.75) points in the biofeedback group and 4.15 (4.44) points in the RRT grou
45 e mean (SD) age was 46.4 (16.2) years in the biofeedback group and 49.4 (20.0) years in the RRT group
46 2%) of 86 participants in the loperamide and biofeedback group and two (2%) of 88 in the loperamide p
47 iod, with instructions to perform exercises (biofeedback group) or to take placebo 3 times per day (c
48  (small bowel obstruction in the placebo and biofeedback group).
49 regarding patient satisfaction: 75.0% of the biofeedback group, 85.5% of the verbal feedback group, a
50             Of these, 25 participants in the biofeedback group, and 20 in the RRT group completed the
51      The signal was shown to patients in the biofeedback group, who were taught to mobilize the diaph
52 ctive value of improved anal pressures after biofeedback has not been clearly established.
53                        Behavioral treatment (biofeedback) has been reported to improve fecal incontin
54                       Heart rate variability biofeedback (HRVB) is a self-regulation intervention tha
55 inary studies suggest heart rate variability biofeedback (HRVB) may reduce craving and negative affec
56                Thus, we examined whether HRV biofeedback intervention affects plasma Alphabeta40, Alp
57 ive, yet it has not been established whether biofeedback is an essential component that heightens the
58 ivalent to placebo, that anal exercises with biofeedback is equivalent to an educational pamphlet, an
59 that multicomponent behavioral training with biofeedback is safe and effective, yet it has not been e
60 y, placebo plus anorectal manometry-assisted biofeedback, loperamide plus education only, and loperam
61 combinations of anorectal manometry-assisted biofeedback, loperamide, education, and oral placebo.
62 se, progressive relaxation, electromyography biofeedback, low-level laser therapy, operant therapy, c
63 ence -4.6 [95% CI -5.9 to -3.4] and CFT plus biofeedback mean difference -4.6 [-5.8 to -3.3]) for act
64 ting that Glut upregulation was related to a biofeedback mediated event.
65 -induced movement therapy, electromyographic biofeedback, mental practice with motor imagery, and rob
66                              Movement sensor biofeedback might enhance treatment effects.
67  placebo plus education (n=42), placebo plus biofeedback (n=84), loperamide plus education (n=88), an
68 the combined intervention of loperamide plus biofeedback (n=86).
69  that after a single session of walking with biofeedback of summary measures of plantarflexor muscle
70 ofeedback are equivalent to oral placebo and biofeedback or loperamide plus an educational pamphlet.
71 e confirmed its efficacy or compared it with biofeedback or other less invasive forms of treatment.
72 ive behavioural therapy (CBT) augmented with biofeedback or relaxation therapy (risk difference (RD)
73 ve behavioural therapy (CBT) with or without biofeedback or relaxation therapy, therapist-assisted mo
74  attributed to ILO were evenly randomized to biofeedback or RRT.
75 ulness but fewer innovative features such as biofeedback or specialized therapies.
76 s important in predicting response to either biofeedback or surgery.
77  Trials assessing combined treatments (e.g., biofeedback plus surgery vs. surgery alone or biofeedbac
78 ncter pressure biofeedback; and (4) hospital biofeedback plus the use of a home electromyelogram biof
79  tonsillectomy and the use of a vibrotactile biofeedback posture monitor.
80                                              Biofeedback presents potential advantages, as it is easi
81        This study aimed to validate a simple biofeedback procedure, guided by abdominothoracic wall m
82 d therapies in NNVD, comparison of different biofeedback programs for treating dysfunctional voiding,
83                            Women assigned to biofeedback received six visits, including strength and
84 patient complaints, symptoms, consultant and biofeedback referrals, investigations, multidisciplinary
85 ch-avoidance conflict-resolution may inspire biofeedback-related techniques to optimize decision-maki
86           Subjects were trained to perform a biofeedback relaxation exercise that reflected electrode
87 canned performing repetitions of four tasks: biofeedback relaxation, relaxation without biofeedback a
88  relaxation, highlighting activity unique to biofeedback relaxation, was associated with enhanced ant
89 be important in predicting outcome following biofeedback retraining include the duration of fecal inc
90 horacic wall movements serve as an effective biofeedback signal for correcting abdominophrenic dyssyn
91           Treatments for fecal incontinence (biofeedback, sphincteroplasty, antidiarrheal and laxativ
92 d breathing via heart rate variability (HRV) biofeedback stimulates vagus-nerve pathways that counter
93 tinence be more clearly defined, that future biofeedback studies elaborate the predictive value of pr
94 raining, which includes the application of a biofeedback system to detect swallowing behavior.
95 dry weight using bioimpedance technology and biofeedback systems designed to prevent rapid fluctuatio
96 ications, transcranial magnetic stimulation, biofeedback, target-specific botulinum toxin injections,
97 ased therapies (n = 9); mindfulness (n = 1), biofeedback techniques (n = 3); cognitive behavioural th
98                                              Biofeedback techniques used to treat urinary and fecal i
99 n the importance of defecation disorders and biofeedback therapies.
100 ay be amenable to pelvic floor retraining by biofeedback therapy (such as dyssynergic defecation).
101                Education, antidiarrheals and biofeedback therapy are the mainstay of management; surg
102 al stimulation, sacral nerve stimulation and biofeedback therapy are under development, but as curren
103 ymptoms appeared; instead, she would perform biofeedback therapy before using the adrenaline autoinje
104 ding dysfunction is equivalent in potency to biofeedback therapy for the treatment of recalcitrant vo
105 s increased after pelvic floor retraining by biofeedback therapy in fecal incontinence; however, the
106                                    Anorectal biofeedback therapy is effective for managing DD and, to
107                                 Pelvic floor biofeedback therapy is effective for treating LAS and de
108                                              Biofeedback therapy is not widely accessible, and many p
109           Conservative approaches, including biofeedback therapy, are the mainstay for managing these
110                                              Biofeedback therapy, hypnotherapy, and peppermint oil ar
111 gradually diminished after the initiation of biofeedback therapy, including pursed lips breathing and
112 odification, behavioural measures, including biofeedback therapy, pharmacotherapy for constipation or
113 educed with EMG-guided, respiratory-targeted biofeedback therapy.
114        Defecatory disorders often respond to biofeedback therapy.
115 ) or to use personalized strategies with HRV biofeedback to decrease heart rate oscillations (Osc-).
116         Here we examined the use of auditory biofeedback to improve accommodative responses to near v
117  = 108) to use slow-paced breathing with HRV biofeedback to increase heart rate oscillations (Osc+) o
118   New research combining neural decoding and biofeedback to target neuroplasticity causally links ear
119                                              Biofeedback to teach pelvic floor muscle control, verbal
120 loor musculature, providing real-time visual biofeedback to the patient during specific pelvic floor
121 nvestigation of intratracheal manometry as a biofeedback tool to improve TEP voicing is needed.
122 aining interval and times of microperimetric biofeedback training (MBFT) in maculopathies.
123                                              Biofeedback training effectively reduced the lag by >=0.
124                                              Biofeedback training has been used to access autonomical
125 h this proof-of-concept, we hypothesize that biofeedback training in myopic children wearing MFCLs mi
126 that accommodation can be changed with short biofeedback training independent of the refractive state
127                    Short periods of auditory biofeedback training to improve the response (reduce the
128 d six visits, including strength and sensory biofeedback training.
129 d to be predictive of successful outcomes in biofeedback treatment are the threshold for external ana
130                                              Biofeedback treatment, but not control sessions, reduced
131 essions) of EMG-guided, respiratory-targeted biofeedback treatment; 11 received 1 control session bef
132 ks (4 visits) of behavioral training without biofeedback (verbal feedback based on vaginal palpation;
133 ge -1.5 points, 95% CI -3.4 to 0.4, p=0.12), biofeedback versus education (-0.7 points, -2.6 to 1.2,
134 ts, -2.6 to 1.2, p=0.47), and loperamide and biofeedback versus placebo and biofeedback (-1.9 points,
135                  Intraoperative vibrotactile biofeedback was associated with improved Rapid Upper Lim
136                                 Vibrotactile biofeedback was associated with reduced ergonomic risk d
137           Neither pelvic floor exercises nor biofeedback was superior to standard care supplemented b
138                  Association of vibrotactile biofeedback with objective measures of ergonomic risk.
139 T, delivered with or without movement sensor biofeedback, with usual care for patients with chronic,
140 nalysis showed that behavioral training with biofeedback yielded a mean 63.1% reduction (SD, 42.7%) i
141                                              Biofeedback yielded no greater benefit than standard car

 
Page Top